Recent studies have indicated that supplementation with DHA effectively relieves NAFLD and NASH by activating the function of the GPR120 (a long-chain fatty acid receptor, FFAR4)-mediated anti-inflammation pathway and inhibiting lipid accumulation in hepatocytes [11,12]. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatotic liver disease.